C45H57NO14
835.9 g/mol
원료의약품위험
Jevtana
CAS183133-96-2
용도 분류
원료의약품
화합물 분류
에스터
주요 용도
의약 원료
Jevtana is the brand name for cabazitaxel, an active pharmaceutical ingredient used in drug manufacturing. It functions as a microtubule inhibitor and is investigated for antineoplastic activity.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 183133-96-2
관련 화합물
강한 관련동일 모체 구조
((1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-((2R,3S)-2-hydroxy-3-((2-methylpropan-2-yl)oxycarbonylamino)-3-phenylpropanoyl)oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl) benzoate;propan-2-one
CAS1426815-65-7
active pharmaceutical ingredient
유사구조 유사유사도 0.83
Docetaxal
CAS125354-16-7
active pharmaceutical ingredient
유사구조 유사유사도 0.79
Docetaxel
CAS114977-28-5
active pharmaceutical ingredient
유사구조 유사유사도 0.79
Docetaxel trihydrate
CAS148408-66-6
active pharmaceutical ingredient
참고동일 카테고리
Upadacitinib
CAS1831899-72-9
Janus kinase inhibitor active pharmaceutical ingredient
참고동일 카테고리
5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride
CAS183204-72-0
active pharmaceutical ingredient
참고동일 카테고리
Clindamycin
CAS18323-44-9
semi-synthetic lincosamide antibiotic
참고동일 카테고리
Erlotinib hydrochloride
CAS183319-69-9
active pharmaceutical ingredient
안전 참조
위험
H302Harmful if swallowed
H311Toxic in contact with skin
H315Causes skin irritation
H317May cause an allergic skin reaction
H318Causes serious eye damage
H335May cause respiratory irritation
H341Suspected of causing genetic defects
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H372Causes damage to organs through prolonged or repeated exposure
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
식별자
IUPAC 이름
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
InChIKey
BMQGVNUXMIRLCK-OAGWZNDDSA-N
SMILES
CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC
동의어 목록 (33)
- EX-A838
- Cabazitaxel (USAN/INN)
- AB01273971-01
- CABAZITAXEL [MART.]
- Cabazitaxel (Jevtana)
- Cabazitaxel (Standard)
- Cabazitaxel Injection
- Cabazitaxelum
- Jevanta
- Jevtana
- Jevtana (TN)
- Jevtana Kit
- RPR-116258A
- TXD 258
- Taxoid XRP6258
- Xrp6258
- cabazitaxel acetonate
- kabazitaxel